OncoSil Medical Ltd
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OSL.AX research report →
Price Chart
About the company
OncoSil Medical Limited, a medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma. The company’s lead product is OncoSil, a single-use brachytherapy device for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia.
- CEO
- Nigel Lange
- IPO
- 2005
- Employees
- 6
- HQ
- Macquarie Park, NSW, AU
Get TickerSpark's AI analysis on OSL.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $35.52M
- P/E
- -1.21
- PEG
- 0.00
- P/S
- 26.65
- P/B
- 5.60
- EV/EBITDA
- -2.13
- Div Yield
- 0.00%
- Gross Margin
- -295.91%
- Op Margin
- -1153.72%
- Net Margin
- -969.26%
- ROE
- -372.27%
- ROIC
- -337.82%
Latest fiscal year · YoY change
- Revenue
- $1.17M+126.6%
- Gross Profit
- $-1,082,846-9.0%
- Op Income
- $-15,488,838
- Net Income
- $-15,099,844-26.7%
- EPS
- $-1.38-25455.6%
- OCF Growth
- -11.4%
- FCF Growth
- -9.6%
- 52W High
- $2.09
- 52W Low
- $0.37
- 50D MA
- $1.05
- 200D MA
- $0.81
- Beta
- 1.23
- RSI (14)
- 48
- Avg Volume
- 250.97K
No earnings-call transcripts are available for OSL.AX yet.
- Free Float
- 94.5%
- Shares Outstanding
- 30.89M
- Float Shares
- 29.18M
Our OSL.AX coverage
Recent articles, reports, and earnings notes.
No research on OSL.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate OSL.AX report →Ferrari gets Jefferies backing as classic car auction prices surge
proactiveinvestors.com · Aug 17
Inside Biotech: OncoSil’s TGA breakthrough puts focus back on pancreatic cancer challenge
proactiveinvestors.com · May 21
FTSE 100 Live: Stocks off to tired start, ConvaTec and Mitchells & Butlers drop
proactiveinvestors.com · May 21
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.